PSMA-Targeted Imaging Agent Posluma Approved to Aid in Prostate Cancer Detection
The approval was based on data from the LIGHTHOUSE and SPOTLIGHT clinical trials.
The approval was based on data from the LIGHTHOUSE and SPOTLIGHT clinical trials.
CABA-201 is a 4-1BB-containing fully human CD19-CAR T cell therapy.
Sparsentan is an endothelin and angiotensin II receptor antagonist.
The recalled product was distributed between October 26, 2021 and August 10, 2022.
The target action dates have been extended by 3 months to allow for extra time to review the applications.
By identifying existing medications that may be repurposed for dementia, clinicians may be able to provide faster treatment for those in need.
Finerenone reduced the incidence of the primary composite endpoint of CV death, nonfatal MI, nonfatal stroke or hospitalization for heart failure by 13%.
To investigate the association between glucocorticoids and and brain structure changes, researchers used data from the UK Biobank.
The placebo-controlled, event-driven DELIVER study included 6263 patients.
Researchers used 2018 data from the National Health Interview Survey to investigate the association.